Clinical Trials Directory

Trials / Completed

CompletedNCT06231433

Effects of Fractional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic Sclerosis

Effect of Factional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic Sclerosis

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
16 (actual)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Women affected by Systemic Sclerosis and Vulvovaginal Atrophy will be submitted to a cycle composed of five vaginal CO2 laser treatment (SmartXide2 V2LR, Monalisa Touch, DEKA, Florence, Italy - Hi Scan V2LR con sonda vaginale a 360 °, dot power 30 watt, dwell time 1000 μs, dot spacing 1000 μm smart stack 1-3, emission mode deka pulse) every 30-40 days. At 1-month follow up from the last vaginal laser treatment (6 months from baseline) vagina and sexual health will be assessed by a 1-5 Likert scale, a 0-10 Visual Analogue Scale for vulvovaginal symptoms and the Female Sexual Function Index.

Conditions

Interventions

TypeNameDescription
DEVICECO2 Vaginal LaserCO2 Vaginal laser

Timeline

Start date
2020-05-01
Primary completion
2022-05-03
Completion
2022-05-03
First posted
2024-01-30
Last updated
2024-01-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06231433. Inclusion in this directory is not an endorsement.

Effects of Fractional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic Sclerosis (NCT06231433) · Clinical Trials Directory